{"id":8358,"date":"2026-08-11T13:32:58","date_gmt":"2026-08-11T17:32:58","guid":{"rendered":"https:\/\/web.uri.edu\/pharmce\/?p=8358"},"modified":"2026-08-24T10:44:34","modified_gmt":"2026-08-24T14:44:34","slug":"69th-annual-heber-w-youngken-jr","status":"publish","type":"post","link":"https:\/\/web.uri.edu\/pharmce\/69th-annual-heber-w-youngken-jr\/","title":{"rendered":"69th Annual Heber W. Youngken, Jr. \u201cLast Chance\u201d Pharmacy Clinic – From Buzz to Best Practice: Advancing Women\u2019s Health and Pharmacy Care"},"content":{"rendered":"\n

69th Annual Heber W. Youngken, Jr. \u201cLast Chance\u201d Pharmacy Clinic<\/h1>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Thursday, November 5th, 2026 | Zoom Opens at 8:15 AM | Program: 8:30AM – 2:45PM<\/h2>\n\n\nRegister – $89<\/a>\n\n\n

Overview<\/h1>\n\n\n\n
\n
\n

Women’s healthcare is evolving rapidly, and pharmacists are playing an increasingly important role in improving access, counseling patients, and optimizing outcomes. Join colleagues for the 69th Annual Heber W. Youngken, Jr. “Last Chance” Pharmacy Clinic for a timely day of continuing education exploring the latest evidence and innovations in women’s health across the lifespan.\n\nNational experts will provide practical updates on menopause management, hormone and non-hormonal therapies, GLP-1 medications beyond weight loss, metabolic health, reproductive health, preventive care through immunization, and Rhode Island pharmacy law. Through evidence-based presentations and patient cases, participants will gain practical strategies they can immediately apply to strengthen patient care in a variety of practice settings.\n\nThe clinic provides 5.0 live contact hours (0.5 CEUs) of continuing pharmacy education credit for pharmacists, including 1 hour of immunization CE and 1 hour of pharmacy law CE.\n<\/p>\n\n\n

Zoom Events Information<\/h1>\n\n

A computer or mobile device with an internet connection and access to Zoom is required to participate in this live webinar.<\/p>\n\n\n\n

All registrants will receive Zoom access instructions by email directly from Zoom Events email address: noreply-zoomevents@zoom.us<\/strong>. This email will be sent to your registration email address the Monday before the conference.<\/p>\n\n<\/div><\/section><\/div>\n\n\n\n

\"\"<\/div>

Accreditation Statement<\/h2>

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based and application-based program will provide 5.0 Contact Hours ( 0.5 CEUs) for pharmacists. <\/p><\/div><\/div>

ACPE\n<\/div><\/a><\/div>\n\n

Target Audience<\/h1>\n\n

Pharmacists in all practice settings.<\/p>\n\n<\/div><\/section><\/div>\n<\/div>\n\n\n\n

Agenda & Learning Objectives<\/h1>\n\n\n\n

*Subject to minor timing changes between now and the event<\/em><\/p>\n\n\n\n

8:30AM<\/strong><\/td> Welcome and Introductions<\/strong>
Mary-Jane Kanaczet, MEd, CHCP<\/em><\/td>		<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
8:45AM<\/strong><\/th>Transforming Women’s Health: Emerging Challenges, New Opportunities, and the Pharmacist’s Role<\/strong><\/strong><\/th><\/tr><\/thead>
Speaker<\/strong><\/td>Kathleen Hill-Besinque, PharmD, MSEd, FASHP, FCSHP, FCPhA, MSCP<\/em><\/td><\/tr>
<\/td>Upon completion of this educational activity, pharmacists will be able to: <\/strong>
– Describe key trends and unmet needs affecting women’s health across the lifespan.
– Discuss the evolving role of pharmacists in improving access to evidence-based women’s healthcare services.
– Identify emerging therapeutic, public health, and practice advancement opportunities impacting women’s health.
– Recognize strategies pharmacists can implement to improve health outcomes and patient engagement in women’s healthcare.<\/td><\/tr>
<\/td>Knowledge-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-044-L01-P<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
9:45AM<\/strong><\/th>Women’s Health Across the Lifespan: Prevention, Immunization, and the Pharmacist’s Role (Immunization CE)<\/strong><\/strong><\/strong><\/th><\/tr><\/thead>
Speaker<\/strong><\/td>Veronica Vernon, PharmD, BCPS, BCACP, MSCP, FAPh<\/em><\/em><\/td><\/tr>
<\/td>Upon completion of this educational activity, pharmacists will be able to: <\/strong>
– Review evidence-based preventive health recommendations relevant to women across the lifespan, including cancer screening, cardiovascular risk reduction, and osteoporosis prevention.
– Describe current immunization recommendations for women during reproductive years, pregnancy, midlife, and older adulthood.
– Identify opportunities for pharmacists to improve access to preventive services through vaccination, screening referrals, and medication optimization.
– Apply patient-centered counseling strategies to address vaccine hesitancy and common misconceptions related to women\u2019s preventive health.<\/td><\/tr>
<\/td>Application-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-047-L06-P<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
10:45AM<\/strong><\/td>Break<\/strong><\/td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
11:00AM<\/strong><\/th>Menopause Management in Clinical Practice: Hormones, Regulatory Considerations, Emerging Therapies, and Patient Cases (Law CE)<\/strong><\/strong><\/strong><\/strong><\/th><\/tr><\/thead>
Speaker<\/strong><\/td>Paris Dade, PharmD<\/em><\/em><\/em><\/td><\/tr>
<\/td>Upon completion of this educational activity, pharmacists will be able to: <\/strong>
– Review current guideline recommendations for the management of vasomotor symptoms, genitourinary syndrome of menopause, and other common menopause-related concerns.
– Compare hormonal and nonhormonal treatment options, including recently approved and emerging therapies for menopause symptom management.
– Discuss legal and regulatory considerations to menopause therapies that influence pharmacy practice and patient care.
– Evaluate patient-specific factors that influence treatment selection, safety, and monitoring of menopause therapies.
– Apply evidence-based treatment strategies through case-based discussions commonly encountered in menopause practice.<\/td><\/tr>
<\/td>Application-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-046-L03-P<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
12:00PM<\/strong><\/td>Dean’s Welcome and Announcement of Scholarships – Virtual Lunch Break<\/strong>
<\/strong>Kerry LaPlante, PharmD, FCCP, FIDSA, FIDP Dean, College of Pharmacy, The University of Rhode Island<\/em><\/td>		<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
12:30PM<\/strong><\/strong><\/th>Beyond Weight Loss: GLP-1s, Metabolic Health, and Emerging Therapies in Pharmacy Practice<\/strong><\/strong><\/strong><\/strong><\/strong><\/th><\/tr><\/thead>
Speaker<\/strong><\/td>Jennifer Newell Leavitt, PharmD, CDCES, CDOE, CVDOE<\/em><\/td><\/tr>
<\/td>Upon completion of this educational activity, pharmacists will be able to: <\/strong>
– Describe physiologic and metabolic changes that contribute to obesity, insulin resistance, and cardiometabolic disease across midlife and aging populations.
– Review current evidence supporting GLP-1\u2013based therapies and emerging pharmacologic approaches for obesity and metabolic disease management.
– Develop patient-centered counseling and monitoring strategies for individuals receiving GLP-1 therapies, including management of adverse effects, adherence, and common misconceptions.
– Discuss emerging therapies for MASH and their implications for pharmacists.<\/td><\/tr>
<\/td>Application-based, 1.0 hr. (0.1 CEU) | UAN: 0060-0000-26-045-L01-P<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
1:30PM<\/strong><\/strong><\/th>Women’s Health OTC Pearls: Separating the Evidence from the Hype<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/th><\/tr><\/thead>
Speaker<\/strong><\/td>Oluwatobi Akinsanya, PharmD<\/em><\/em><\/td><\/tr>
<\/td>Upon completion of this educational activity, pharmacists will be able to: <\/strong>
– Describe current evidence and guideline recommendations for over-the-counter therapies for menopause.
– Identify effective patient counseling strategies and situations that warrant referral to an appropriate healthcare professional.<\/td><\/tr>
<\/td>Knowledge-based, 0.5 hr. (0.05 CEU) | UAN: 0060-0000-26-048-L01-P<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
2:00PM<\/strong><\/strong><\/th>Advances in Endometriosis Management: A Pharmacotherapy Update<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/th><\/tr><\/thead>
Speaker<\/strong><\/td>Zumar Smith, PharmD<\/em><\/strong><\/em><\/td><\/tr>
<\/td>Upon completion of this educational activity, pharmacists will be able to: <\/strong>
-Review current evidence and guideline recommendations for the pharmacologic management of endometriosis.
– Individualize treatment recommendations based on symptom severity, reproductive goals, comorbidities, and medication safety considerations.<\/td><\/tr>
<\/td>Application-based, 0.5 hr. (0.05 CEU) | UAN: 0060-0000-26-049-L01-P<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
2:30PM<\/strong><\/strong><\/td>Program Summary and Evaluation Instructions<\/strong>
Mary-Jane Kanaczet, MEd, CHCP<\/em><\/td>		<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
2:45PM<\/strong><\/strong><\/td>Adjourn<\/strong><\/td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
<\/div>\n\n\n\n

Speakers<\/h1>\n\n\n\n
\n
\"\"<\/div>

Oluwatobi (Tobi) Akinsanya, PharmD<\/h2>

Clinical Quality Evolution Fellow
CVS Health<\/strong>

Oluwatobi “Tobi” Akinsanya is a pharmacist and emerging healthcare leader whose experience spans community pharmacy, health systems practice, and the pharmaceutical industry. He has worked with CVS Pharmacy, Advocate Health, and Johnson & Johnson Innovative Medicine, while also serving in leadership roles within the Student National Pharmaceutical Association. His professional interests include patient care, health equity, clinical research, and advancing opportunities for future pharmacy professionals.<\/p><\/div><\/div>

Linkedin<\/div><\/a><\/div><\/div>\n\n\n\n
\"\"<\/div>

Paris Dade, PharmD<\/h2>

Assistant Professor
Albany College of Pharmacy and Health Sciences<\/strong>

Paris Dade is a pharmacist based in New York with interests in patient-centered care, diabetes management, and healthy aging. Licensed in New York, she has earned additional credentials in age-friendly pharmacy practice and diabetes-related care, reflecting a commitment to improving outcomes for diverse patient populations. Her work focuses on delivering clinical expertise while supporting patients in managing chronic conditions and achieving long-term wellness.<\/p><\/div><\/div>

linkedin<\/div><\/a><\/div><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Kathleen Hill-Besinque, PharmD, MSEd, FCSHP, FASHP, FCPhA, MSCP<\/h2>

Professor Emerita
Chapman University, School of Pharmacy<\/strong>

Kathleen Hill-Besinque is Professor Emerita of Pharmacy at Chapman University School of Pharmacy and a nationally recognized leader in pharmacy education and women’s health. Over a distinguished career spanning academic, community, ambulatory care, and health-system pharmacy practice, she has served in numerous leadership roles, including President of the California Pharmacists Association. Her work has focused on advancing pharmacy practice, public health advocacy, contraception access, and menopause care.<\/p><\/div><\/div>

linkedin<\/div><\/a><\/div><\/div>\n\n\n\n
\"\"<\/div>

Jennifer Leavitt, PharmD, CDCES, CDOE, CVDOE<\/h2>

Director of Clinical Pharmacy
Rhode Island Primary Care Physicians Corporation<\/strong>

Jennifer Leavitt is Director of Pharmacy for Rhode Island Primary Care Physicians Corporation, where she leads clinical pharmacy programs that support primary care practices and patient care initiatives across the organization. A graduate of the University of Rhode Island College of Pharmacy, she has extensive experience in ambulatory care, diabetes education, cardiovascular risk management, and population health. Prior to joining RIPCPC, she held pharmacist and clinical pharmacist roles with CVS Health and has been active in professional pharmacy organizations throughout her career.<\/p><\/div><\/div>

Linkedin<\/div><\/a><\/div><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>

Zumar Smith, PharmD<\/h2>

Pharmacy Fellow, Retail Clinical & Quality Standards
CVS Health<\/strong>

Zumar Smith is a pharmacist and healthcare quality professional currently serving as a Clinical Quality & Evolution Fellow with CVS Health. A graduate of Touro College of Pharmacy, she has experience in hospital, community, and managed care pharmacy settings, including work with Long Island Jewish Medical Center and CVS Health. Her interests center on quality improvement, population health, and advancing innovative approaches to patient care delivery.<\/p><\/div><\/div>

linkedin<\/div><\/a><\/div><\/div>\n\n\n\n
\"\"<\/div>

Veronica Vernon, PharmD, BCPS, BCACP, MSCP<\/h2>

Associate Professor and Department Chair
College of Health Professions,<\/strong>
Pharmacy Practice
Butler University<\/strong>

Veronica Vernon is a pharmacist, educator, and advocate who serves as Chair of Pharmacy Practice and a tenured faculty member at Butler University College of Health Professions. A board-certified pharmacotherapy and ambulatory care specialist, she is nationally recognized for her work in primary care, women’s health, menopause management, and gender-affirming care. In addition to her academic responsibilities, she has maintained an active clinical practice within the Veterans Health Administration and is committed to training the next generation of pharmacists.<\/p><\/div><\/div>

linkedin<\/div><\/a><\/div><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

Requirements for Credit<\/h1>\n\n\n\n

A program evaluation must be completed at www.uripharmacycpd.org<\/a> within 60 days of the live program date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.<\/p>\n\n\n

Evaluation<\/h1>\n\n

All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs. <\/p>\n\n<\/div><\/section>\n\n\n

<\/div>\n\n\n\n

Registration<\/h1>\n\n\n\n
\n

Registration for this program is $89<\/h1>\n\n

<\/p>\n\n<\/div><\/section>\n\nRegister<\/a><\/div>\n\n\n\n

\n